the lupus drug looks like a better version of the hgsi compound
What gives you reason to believe that ANTH's lupus drug looks like a better version of HGSI's Benlysta? Is this based on specific trial data that has looked better than Benlysta or is this based on MoA of ANTH's drug theoretically being superior in some way?
Market Data 
Markets 
AI
